The pan-European STOXX 600 index ended 0.7% lower, making the index’s fourth decline in five trading sessions. The healthcare ...

BENGALURU] European shares closed lower on Wednesday (Mar 26), dragged by technology and healthcare stocks, while investors ...

Cigna CEO David Cordani is not convinced of the benefits of GLP-1s for weight-loss patients and said the US is the only ...

A U.S. federal judge approves a deal between Novo Nordisk (NVO) and Minnesota that settled a lawsuit over high insulin prices ...

European shares closed lower on Wednesday, dragged by technology and healthcare stocks, while investors remained concerned ...

Novo Nordisk is betting on the future with a $2-billion deal to buy rights to a Chinese obesity drug. But investors remain unimpressed.

European markets closed lower due to losses in technology and healthcare sectors as fears of upcoming U.S. tariffs linger.

Indian markets ended lower, snapping a seven-day winning streak as investors booked profits ahead of U.S. tariff ...

European companies that are spending big on generative artificial intelligence need to start showing returns on their massive outlays by next year, or risk investors losing patience after they paid ...

The Johannesburg Stock Exchange (JSE) has welcomed 16 new exchange-traded notes (ETNs) from FNB, giving South African ...

Dewpoint will present two posters at AACRCondensate modulators (c-mods) demonstrate robust anti-tumor effects across multiple types of ...

MRK in-licenses an experimental lipoprotein(a) inhibitor from China's Jiangsu Hengrui. This transaction is expected to be ...